This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Development Center for Biotechnology, Tunghai University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 97 
1 out of 24 Years Active: 2022
Title: Hui-Jan Hsu: Innovator in Antibody-Drug Conjugates
Introduction
Hui-Jan Hsu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. His innovative work has the potential to enhance cancer treatment options.
Latest Patents
Hsu holds a patent for "Antibody-drug conjugates and uses thereof." This immunoconjugate comprises an anti-EGFR antibody or a binding fragment thereof, along with a kinase inhibitor. This invention represents a significant advancement in targeted cancer therapies.
Career Highlights
Throughout his career, Hui-Jan Hsu has worked with notable institutions such as the Development Center for Biotechnology and Tunghai University. His experience in these organizations has allowed him to refine his expertise in biotechnology and drug development.
Collaborations
Hsu has collaborated with esteemed colleagues, including Shih-Hsien Chuang and Wei-Ting Chao. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Hui-Jan Hsu is a key figure in the field of biotechnology, with a focus on antibody-drug conjugates. His innovative patent and collaborations highlight his commitment to advancing cancer treatment. His work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile